MVA-BN based burkholderia vaccine development

Ended Definitive Contract Awarded Last action

Contract number
HDTRA114C0017
Awardee
Awarding agency
Obligated
$510,894

Award facts

Contract value 100% obligated
$510,894.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 7 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Denmark

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $510,894

About this award

The Defense Threat Reduction Agency awarded a $510,894 definitive contract to Bavarian Nordic A / S for MVA-BN based Burkholderia vaccine development on January 27, 2014, under cost-plus-fixed-fee pricing with no set-aside.

Place of performance is Denmark. The contract ceiling value is $510,894, with an ultimate completion date of June 30, 2015.

Quick answers

Who was awarded contract HDTRA114C0017?

HDTRA114C0017 was awarded to Bavarian Nordic A / S by Defense Threat Reduction Agency (Department of Defense) on January 27, 2014.

How much is contract HDTRA114C0017 worth?

The government has obligated $510,894 on HDTRA114C0017.

Was contract HDTRA114C0017 competed?

The extent of competition for HDTRA114C0017 was full and open competition. The government received 7 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award